Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
University of Maryland, Baltimore
Baltimore, Maryland
NEW! NEW!
NEW! NEW!
Georgetown University
Washington, D.C.
NEW! NEW!
NEW! NEW!
NEW! NEW!
University of California Davis Health System
Sacramento, California
NEW! NEW!
NEW! NEW!
Central Michigan University
Mount Pleasant, Michigan
NEW! NEW!
NEW! NEW!
NEW! NEW!
University of California Davis
Davis, California
NEW! NEW!
Baltimore City Community College
Main Campus (Liberty Heights)
NEW! NEW!
University of Michigan - Ann Arbor
Ann Arbor, Michigan
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
Babson College
Wellesley, Massachusetts
NEW! NEW!
The Ohio State University
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
Boston University
Boston, Massachusetts
NEW! NEW!
Loading... Please wait.
Clinical Research Coordinator
The I-SPY Program involves novel trial designs in the setting of neoadjuvant chemotherapy to accelerate the drug development process. Our goal is to introduce and rapidly test novel targeted strategies for women at high risk for recurrence, at the time of primary cancer diagnosis, rather than waiting until they develop metastatic disease. Neoadjuvant therapy allows visualization of tumor response to treatment, and thus is the ideal platform to identify mechanisms of resistance, develop diagnostic markers, and individualize therapy. I-SPY 2, a phase 2 adaptive randomization trial process that will test up to 12 new drugs in approximately 800 patients over 5 years. I-SPY 2 is a unique public/private partnership between QuantumLeap Healthcare Collaborative and the National Can
Loading. Please wait.
